Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Use of Generic Drugs Increasing at Tokyo Municipal Hospitals
August 28, 2006
- Drug Makers Actively Outsourcing to India: MediBic
August 28, 2006
- Doctors Object to Generics Use Promotion Service
August 28, 2006
- STOP PRESS／Schering-Plough Withdraws NDA for Garenoxacin It Submitted to FDA
August 28, 2006
- GENERIC NEWS IN BRIEF
August 28, 2006
- Wholesalers Express Opposition to Annual NHI Price Revision
August 28, 2006
- Once-Yearly NHI Price Revisions Too Costly: FJPWA's President Matsutani
August 28, 2006
- Discussions on Healthcare Reform Should Focus on Public Interest: Mr Urushibata of NPhA
August 28, 2006
- Kenporen Member Societies Report Surplus 3 Years in a Row in FY2005
August 21, 2006
- New Antibody Manufacturing Technology Established: Chiome Bioscience
August 21, 2006
- Korosho to Review Its Gastric Cancer Detection Program
August 21, 2006
- SymBio Initiates PI Clinical Trial of Bendamustine
August 21, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 21, 2006
- Actual R&D Tax Reduction Rate Was Only 7.3% in FY2005: JPMA
August 21, 2006
- DSP to Place Top Priority on Domestic Infrastructure in Mid-Term Plan
August 21, 2006
- SEMIANR Micardis Improves Insulin-Resistant Hypertension
August 21, 2006
- JMIRI to Launch Prescription Data Analysis Service
August 21, 2006
- R&D NEWS IN BRIEF
August 21, 2006
- BUSINESS NEWS IN BRIEF ～1～
August 21, 2006
- BUSINESS NEWS IN BRIEF ～2～
August 21, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…